Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABAL.L Regulatory News (ABAL)

  • There is currently no data for ABAL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

11 Jun 2012 08:30

RNS Number : 0480F
Imaginatik PLC
11 June 2012
 

 

 

11 June 2012

Imaginatik Plc

 

("Imaginatik" or "the Company")

 

Directors' Dealings

 

The Company announced earlier today that it was proposing to raise up to £1million before expenses through a conditional placing of up to 333,333,333 new ordinary shares (the "Placing Shares") with institutional and other investors at a price of 0.3p per Placing Share (the "Placing") and that it had received irrevocable commitments to subscribe for 285,833,333 Placing Shares and expressions of interest from certain Directors of the Company to subscribe for a further 47,500,000 Placing Shares in the Placing on the same terms.

 

Following the release of its audited results for the year ended 31 March 2012, the Company is pleased to announce that Messrs Cooper, Charles and Gammon, Directors of the Company, have conditionally subscribed in the Placing for in aggregate 47,500,000 Placing Shares, as set out below, at a price of 0.3p per Placing Share.

 

In aggregate, the Company has therefore conditionally raised £1 million before expenses through a conditional placing of 333,333,333 new ordinary shares at a price of 0.3p per Placing Share.

 

The 333,333,333 new ordinary shares to be issued pursuant to the Placing will be credited as fully paid and will rank pari passu in all respects with the existing ordinary shares, including the right to receive all dividends and other distributions declared on or after the date on which they are issued.

 

Application will be made for admission of the 333,333,333 new ordinary shares to trading on AIM ("Admission") and, subject to the requisite shareholder approval for the Placing being obtained at the General Meeting to be held on 27 June 2012, it is expected that Admission will be effective on or around 8.00 am on 28 June 2012.

 

Directors' participation in the Placing

The following directors of the Company are participating in the Placing at the Placing Price:

 

Director

Number of Placing Shares conditionally subscribed for

Amount subscribed

£

Number of shares held including Placing Shares

Percentage of enlarged issued share capital at Admission

Options held

Simon Charles

7,500,000

22,500

19,511,771

2.31

2,000,000

Matt Cooper

 25,000,000

75,000

80,139,615

9.47

19,062,500

David Gammon

 15,000,000*

45,000

27,442,564**

3.24

2,000,000

 

*includes a subscription for 8,333,333 Placing Shares for the sum of £25,000 by Sarah Gammon, the wife of David Gammon.

 

** The interest of David Gammon includes those of his wife.

 

 

The issue of the 47,500,000 Placing Shares to Directors of the Company is deemed a related party transaction under the AIM Rules for Companies. Shawn Taylor, Luis Solis, Brian Hays and Nick Goss, the independent directors, consider, having consulted with Northland Capital Partners Limited as the Company's Nominated Adviser, that the terms of the Directors' participation in the Placing are fair and reasonable insofar as shareholders of the Company are concerned.

 

Issue of options

 

Subject to Admission, Northland Capital Partners Limited has been issued 5,895,833 options to subscribe for new ordinary shares in the Company at a price of 0.5p per new ordinary share for a period of five years from the date of the General Meeting.

 

Total voting rights

 

Following the Admission of the 333,333,333 new ordinary shares to be issued pursuant to the the Placing, the Company's total issued share capital will comprise of 846,365,443 ordinary shares. The Company does not hold any ordinary shares in treasury. Therefore the total number of shares with voting rights in the Company will be 846,365,443. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company following Admission.

 

 

For further information please contact:

 

Imaginatik plc

Tel: 020 7917 2975

Matt Cooper, Chairman / Shawn Taylor, CFO

Northland Capital Partners Limited

Tel: 020 7796 8800

Gavin Burnell / Edward Hutton

John Howes / Alice Lane (Broking)

 

Newgate Threadneedle

Tel: 020 7653 9850

Caroline Evans-Jones / Hilary Millar

 

About Imaginatik

Imaginatik provides a range of Innovation solutions comprised of consultancy, enterprise software and program management to deliver innovation results to companies such as The World Bank, NYSE, The Chubb Group of Insurance Companies, Boeing, Pfizer, Goodyear, Paccar, Kellogg and Cargill. Few companies possess the internal capability to consistently generate fresh ideas, identify those worth pursuing and reliably transform them into real, value-enhancing assets. Imaginatik's mission is to help these companies build sustainable innovation competencies.

 

Imaginatik is a public company whose shares are traded on the AIM market of the London Stock Exchange (LSE:IMTK.L) and is a World Economic Forum Technology Pioneer with offices in Boston, MA, and Winchester, UK. For more information visit www.imaginatik.com.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSFMMPTMBABBLT
Date   Source Headline
27th Sep 20187:30 amRNSSuspension - Imaginatik plc
26th Sep 20187:00 amRNSUpdate on potential equity investment
17th Sep 20187:00 amRNSUpdate on potential equity investment
11th Sep 201811:35 amRNSUpdate regarding Nominated Adviser
11th Sep 20187:00 amRNSFinal Results
4th Sep 20187:00 amRNSUpdate on potential equity investment
29th Aug 20189:22 amRNSHolding(s) in Company
28th Aug 20189:12 amRNSHolding(s) in Company
24th Aug 20183:39 pmRNSHolding(s) in Company
17th Aug 20183:40 pmRNSIssue of Equity
26th Jul 20187:00 amRNSNew Finance Agreement
25th Jul 20181:05 pmRNSStmnt re Share Price Movement
10th Jul 20184:56 pmRNSHolding(s) in Company
10th Jul 20189:48 amRNSHolding(s) in Company
10th Jul 20187:00 amRNSAppointment of CEO
3rd Jul 20185:45 pmRNSHolding(s) in Company
3rd Jul 20187:00 amRNSIssue of Equity
29th Jun 201810:46 amRNSResult of General Meeting and Total Voting Rights
22nd Jun 20187:00 amRNSContract Win
18th Jun 201812:59 pmRNSHolding(s) in Company
15th Jun 20187:00 amRNSRelease of mobile update to Innovation Central
14th Jun 20187:00 amRNSPosting of circular and notice of general meeting
5th Jun 20185:40 pmRNSHolding(s) in Company
5th Jun 20187:00 amRNSResult of strategic review and new funding
29th May 20187:00 amRNSUpdate on sales process and funding
1st May 20187:00 amRNSTrading Statement
21st Mar 20187:00 amRNSUpdate on strategic review and formal sale process
14th Feb 201812:38 pmRNSForm 8.3 - [Imaginatik plc]
12th Feb 20185:51 pmRNSForm 8.3 - Imaginatik plc
9th Feb 20185:50 pmRNSForm 8.3 - Imaginatik
9th Feb 20185:48 pmRNSForm 8.3 - Imaginatik
8th Feb 20183:36 pmRNSHolding(s) in Company
1st Feb 20183:04 pmRNSForm 8 (DD) - Imaginatik plc
1st Feb 201811:36 amRNSForm 8.3 - Imaginatik PLC
1st Feb 20187:00 amRNSForm 8 (OPD) - Imaginatik plc
1st Feb 20187:00 amRNSStrategic review including formal sale process
7th Dec 20177:00 amRNSHalf-year Report
29th Sep 20177:00 amRNSGrant of Options
27th Sep 20177:00 amRNSContract Win
20th Sep 20179:37 amRNSHolding(s) in Company
7th Sep 20175:50 pmRNSResult of AGM
15th Aug 20178:00 amRNSNotice of AGM
7th Aug 20177:00 amRNSFinal Results
10th Jul 201710:47 amRNSHolding(s) in Company
5th Jul 20174:32 pmRNSHolding(s) in Company
4th Jul 20179:51 amRNSHolding(s) in Company
4th Jul 20177:00 amRNSHolding(s) in Company
3rd Jul 201711:10 amRNSResult of Open Offer and Total Voting Rights
27th Jun 20177:00 amRNSResult of GM and Total Voting Rights
9th Jun 20171:04 pmRNSPlacing and Open Offer to raise up to £1.9 million

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.